Century Therapeutics, Inc. - IPSC Net earnings per share for the last 12 months

Century Therapeutics (IPSC) - corporate logo

Century Therapeutics (IPSC) focuses on developing innovative oncology treatments, investing in scientific research and patents without current profit inflows. The company is fighting for leadership in the high-tech sector, betting on its unique platform and the search for partners. This chart reflects that the asset value on GURU.Markets is -97.40, highlighting the risks of massive expenditures and the complexities of product certification.

centurytx.com (IPSC): Earnings per share for the last twelve months from 02/11/2024 to 11/17/2026

Financial and market metric breakdowns for Century Therapeutics, Inc. (IPSC)

Fundamental company valuation:IPSC Century Tx
Flagship merchandise of centurytx.com

To minimize long-term risks, investors must correlate capitalization rates with net profit dynamics. In the context of Century Therapeutics (IPSC) and its R&D leadership in iPSC therapy, the 12-month annual earnings per share growth on GURU.Markets reflects the efficiency of converting technological potential into financial results, measuring the percentage change in EPS (TTM) to determine fair value and prevent overpaying for the asset.